Analyst Reco. Personalis, Inc.

Equities

PSNL

US71535D1063

Market Closed - Nasdaq Other stock markets 21:00:00 02/05/2024 BST			5-day change	1st Jan Change
1.6 ^USD	+3.23%		+28.00%	-23.81%

04-30	Lake Street Starts Personalis With Buy Rating, $4 Price Target	MT
03-26	Personalis, Inc. Announces Publication Validating Next Personal Test for Ultra-Sensitive MRD Detection and Cancer Treatment Response Monitoring	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lake Street Starts Personalis With Buy Rating, $4 Price Target	04-30	MT
Needham Raises Price Target on Personalis to $3.50 From $2.30, Maintains Buy Rating	02-29	MT
Needham Cuts Price Target on Personalis to $2.30 From $7, Maintains Buy Rating	11-08	MT
HC Wainwright Adjusts Price Target on Personalis to $7.50 From $10, Maintains Buy Rating	09/08/23	MT
Needham Trims Price Target on Personalis to $7 From $8, Maintains Buy Rating	04/05/23	MT
Morgan Stanley Adjusts Price Target on Personalis to $5 From $11, Maintains Equal-Weight Rating	27/02/23	MT
HC Wainwright Trims Price Target on Personalis to $10 From $13, Maintains Buy Rating	24/02/23	MT
Needham Upgrades Personalis to Buy From Hold, Says Encouraged by Cost Reductions, Price Target is $8	06/02/23	MT
HC Wainwright Adjusts Personalis' Price Target to $13 From $26, Keeps Buy Rating	03/11/22	MT
Citigroup Adjusts Price Target on Personalis to $6 From $8, Maintains Buy Rating	03/11/22	MT
Citigroup Lowers Personalis' Price Target to $8 From $14, Maintains Buy Rating	04/08/22	MT
HC Wainwright Adjusts Personalis' Price Target to $26 From $30, Reiterates Buy Rating	04/08/22	MT
Citigroup Adjusts Personalis' Price Target to $14 from $18, Keeps Buy Rating	05/05/22	MT
HC Wainwright Adjusts Personalis' Price Target to $30 From $38, Reiterates Buy Rating	05/05/22	MT
HC Wainwright Adjusts Personalis Price Target to $38 From $50, Maintains Buy Rating	25/02/22	MT
Citigroup Adjusts Personalis Price Target to $18 From $30, Maintains Buy Rating	25/02/22	MT
Oppenheimer Adjusts Personalis' Price Target to $24 From $30, Maintains Outperform Rating	25/02/22	MT
Morgan Stanley Adjusts Personalis Price Target to $14 From $25, Maintains Equalweight Rating	15/02/22	MT
Morgan Stanley Downgrades Personalis to Equalweight from Overweight, Adjusts Price Target to $25 from $32	08/11/21	MT
Needham Downgrades Personalis to Hold From Buy on VA Program Uncertainty, Cash Burn, Model Change; $28 PT Removed	03/11/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Personalis, Inc.

Equities

PSNL

US71535D1063

Analyst Reco.

Filters